Physician profile
Aashish Sagar
NPI 1083607816
$6,845.36
in general payments reported to CMS, 2019-2025
11 companies · $772 in 2025
The $772 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,890 · 2020: $423 · 2021: $306 · 2022: $998 · 2023: $1,495 · 2024: $962 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,228.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,390.06 | 2019-2025 | Aveir, Assurity, Gallant |
| Boston Scientific Corporation | $866.11 | 2019-2025 | Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $410.12 | 2019-2025 | Lifevest |
| Ethicon INC. | $208.94 | 2020-2023 | Monarch Platform |
| Inari Medical, INC. | $187.11 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Edwards Lifesciences Corporation | $185.43 | 2022 | |
| Medtronic Vascular, INC. | $162.66 | 2019 | |
| Integra Lifesciences Corporation | $160.87 | 2023 | Integra, Omnigraft, Surgimend |
| Bayer Healthcare Pharmaceuticals INC. | $147.91 | 2024 | |
| Acell, INC. | $100.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aashish Sagar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.